Literature DB >> 29407047

Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus.

Anders Jorsal1, Henrik Wiggers1, John J V McMurray2.   

Abstract

This article briefly discusses the epidemiology of heart failure and diabetes and summarizes the key findings from the recent cardiovascular outcome trials in patients with type 2 diabetes, with a focus on heart failure as an endpoint.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac function; Cardiovascular events; Glucose lowering therapy; Glycemia; Heart failure; Type 2 diabetes mellitus

Mesh：

Substances：

Year:  2017        PMID： 29407047     DOI： 10.1016/j.ecl.2017.10.007

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  7 in total

Review 1.  SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.

Authors:  Subodh Verma; John J V McMurray
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

2.  L-Carnitine: An Antioxidant Remedy for the Survival of Cardiomyocytes under Hyperglycemic Condition.

Authors:  Fernanda Vacante; Pamela Senesi; Anna Montesano; Alice Frigerio; Livio Luzi; Ileana Terruzzi
Journal:  J Diabetes Res       Date:  2018-12-09       Impact factor: 4.011

3.  Efficacy of ivabradine for heart failure: A protocol for a systematic review of randomized controlled trial.

Authors:  En-Zhong Xue; Ming-Hui Zhang; Chun-Li Liu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

4.  The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT).

Authors:  Henrik Wiggers; Lars Køber; Gunnar Gislason; Morten Schou; Mikael Kjær Poulsen; Søren Vraa; Olav Wendelbo Nielsen; Niels Eske Bruun; Helene Nørrelund; Malene Hollingdal; Anders Barasa; Morten Bøttcher; Karen Dodt; Vibeke Brogaard Hansen; Gitte Nielsen; Anne Sejr Knudsen; Jens Lomholdt; Kirsten Vilain Mikkelsen; Bartlomiej Jonczy; Jens Brønnum-Schou; Monica Petronela Poenaru; Jawdat Abdulla; Ilan Raymond; Kiomars Mahboubi; Karen Sillesen; Kristine Serup-Hansen; Jette Sandberg Madsen; Søren Lund Kristensen; Anders Hostrup Larsen; Hans Erik Bøtker; Christian Torp-Petersen; Hans Eiskjær; Jacob Møller; Christian Hassager; Flemming Hald Steffensen; Bo Martin Bibby; Jens Refsgaard; Dan Eik Høfsten; Søren Mellemkjær; Finn Gustafsson
Journal:  Am Heart J       Date:  2020-10-09       Impact factor: 4.749

5.  The Effect of Ivabradine on Hospitalization of Heart Failure Patients: A Retrospective Cohort Study.

Authors:  Sara Al-Balushi; Mohammed Fasihul Alam; Abdul Rehman Abid; Amal Sharfi
Journal:  Heart Views       Date:  2021-10-11

Review 6.  Revisiting the Diabetes-Heart Failure Connection.

Authors:  Markus Wallner; Deborah M Eaton; Dirk von Lewinski; Harald Sourij
Journal:  Curr Diab Rep       Date:  2018-10-20       Impact factor: 4.810

Review 7.  Clinical efficacy, safety and tolerability of aliskiren monotherapy: a protocol for an umbrella review.

Authors:  Qiyuan Zhao; Jiantong Shen; Jingya Lu; Fan Li; Qi Jiang; Yuanyuan Wang
Journal:  BMJ Open       Date:  2020-01-21       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.